|
³ª¿ìÆÊÄÁ¼³Æà |
Áß°ßÁ¦¾à»ç ÇǺμºÇü PM ±¸ÀÎ
¼¿ï °³²±¸ | Çз¹«°ü |
¸¶ÄÉÆÃ/±âȹ/±³À° |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.10 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
¹é½ÅPM/±¹³»»óÀ§±ÇÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
09.03 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Sr. PM(È£Èí±âÁ¦Ç°)/±¹³»»óÀ§±ÇÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
8³â¡è |
ä¿ë½Ã |
10.08 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Business Development Manager(¾È°ú)/¿Ü±¹°èMedical(¾È°ú)ȸ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
12.30 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Marketing Associate/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
08.22 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
BD & Marketing Mgr/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
10.13 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Commercial Director/±¹³»À¯¸íÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
15³â¡è |
ä¿ë½Ã |
01.25 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
OTC/OTX Business Manager/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
10³â¡è |
ä¿ë½Ã |
10.15 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Marketing Head/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
10³â¡è |
ä¿ë½Ã |
10.01 |
|
|
¾Æµ¥ÄÚÄÚ¸®¾Æ |
RA & QC, QA Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
03.01 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Head of Marketing/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
7³â¡è |
ä¿ë½Ã |
10.13 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
¾È°úÁ¦Ç° ¸¶ÄÉÆôã´çÀÚ/±¹³»À¯¸íÁ¦¾àȸ»ç
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
11.09 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Ç×¾ÏÁ¦Product Manager/»óÀ§±ÇÁ¦¾à»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
07.03 |
|
|
Ä¿¸®¾îÄɾî |
¿Ü±¹°èÇコÄɾî±â±¸ Policy Manager(´ë°ü¾÷¹«)
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
10³â¡è |
ä¿ë½Ã |
12.19 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Market Access Specialist/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
11.22 |
|